Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Gilliland

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Proteins|March 14, 2014
Canonical structures of short CDR-L3 in antibodiesAlexey Teplyakov, Gary L Gilliland
Current Opinion in Structural Biology|August 16, 2016
Engineering antibody therapeuticsMark L Chiu, Gary L Gilliland
Alzheimer'S Research & Therapy|August 24, 2017
A coiled conformation of amyloid-β recognized by antibody C706Alexey Teplyakov, Galina Obmolova, Gary L Gilliland
Biochemistry and Biophysics Reports|December 22, 2017
Structural insights into chemokine CCL17 recognition by antibody M116Alexey Teplyakov, Galina Obmolova, Gary L Gilliland
Acta Crystallographica. Section D, Biological Crystallography|May 31, 2002
The Biological Macromolecule Crystallization Database: crystallization procedures and strategiesGary L Gilliland, Michael Tung, Jane E Ladner
Mitochondrion|August 27, 2005
MitoMorphy: an alignment and annotation tool for human mitochondrial DNA polymorphismsVeerasamy Ravichandran, Ram D Sriram, Gary L Gilliland
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 9, 2010
Noncanonical conformation of CDR L1 in the anti-IL-23 antibody CNTO4088Alexey Teplyakov, Galina Obmolova, Alison Rogers, et al.
Proteins|March 1, 2018
Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected foldAlexey Teplyakov, Galina Obmolova, Jinquan Luo, et al.
Acta Crystallographica. Section F, Structural Biology Communications|May 5, 2017
Crystal structure of CD27 in complex with a neutralizing noncompeting antibodyAlexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2012
Leveraging SBDD in protein therapeutic development: antibody engineeringGary L Gilliland, Jinquan Luo, Omid Vafa, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Proteins|March 14, 2014
Canonical structures of short CDR-L3 in antibodiesAlexey Teplyakov, Gary L Gilliland
Current Opinion in Structural Biology|August 16, 2016
Engineering antibody therapeuticsMark L Chiu, Gary L Gilliland
Alzheimer'S Research & Therapy|August 24, 2017
A coiled conformation of amyloid-β recognized by antibody C706Alexey Teplyakov, Galina Obmolova, Gary L Gilliland
Biochemistry and Biophysics Reports|December 22, 2017
Structural insights into chemokine CCL17 recognition by antibody M116Alexey Teplyakov, Galina Obmolova, Gary L Gilliland
Acta Crystallographica. Section D, Biological Crystallography|May 31, 2002
The Biological Macromolecule Crystallization Database: crystallization procedures and strategiesGary L Gilliland, Michael Tung, Jane E Ladner
Mitochondrion|August 27, 2005
MitoMorphy: an alignment and annotation tool for human mitochondrial DNA polymorphismsVeerasamy Ravichandran, Ram D Sriram, Gary L Gilliland
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 9, 2010
Noncanonical conformation of CDR L1 in the anti-IL-23 antibody CNTO4088Alexey Teplyakov, Galina Obmolova, Alison Rogers, et al.
Proteins|March 1, 2018
Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected foldAlexey Teplyakov, Galina Obmolova, Jinquan Luo, et al.
Acta Crystallographica. Section F, Structural Biology Communications|May 5, 2017
Crystal structure of CD27 in complex with a neutralizing noncompeting antibodyAlexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2012
Leveraging SBDD in protein therapeutic development: antibody engineeringGary L Gilliland, Jinquan Luo, Omid Vafa, et al.
Pageof 8